Table 2 Thyroid dysfunction and dyslipidemia in different CKD stages
From: Thyroid dysfunction and dyslipidemia in chronic kidney disease patients
Variables | All patients N = 360 | Stage 3 N = 144 | Stage 4 N = 156 | Stage 5 N = 60 | P value |
|---|---|---|---|---|---|
Thyroid status | |||||
Euthyroidism | 61.4 % (221) | 29.4 % (106) | 24.7 % (89) | 7.2 % (26) | <0.001 |
Subclinical hypothyroidism | 27.2 % (98) | 6.1 % (22) | 13.9 % (50) | 7.2 % (26) | <0.001 |
Overt hypothyroidism | 8.1 % (29) | 2.5 % (9) | 3.3 % (12) | 2.2 % (8) | 0.232 |
Subclinical hyperthyroidism | 3.3 % (12) | 1.9 % (7) | 1.4 % (5) | - | 0.21 |
Hypercholesterolemia (Total cholesterol > 200 mg/dL) | 34.4 % (124) | 15.5 % (56) | 14.1 % (51) | 4.7 % (17) | 0.292 |
Low HDL cholesterol (HDL cholesterol <40 mg/dL) | 34.1 % (123) | 13.3 % (48) | 15.5 % (56) | 5.2 % (19) | 0.811 |
Undesirable LDL cholesterol (LDL cholesterol > 100 mg/dL) | 35 % (126) | 15.5 % (56) | 13.8 % (50) | 5.5 % (20) | 0.443 |
Hypertriglyceridemia (Triglyceride > 200 mg/dL) | 36.6 % (132) | 13.8 % (50) | 16.6 % (60) | 6.1 % (22) | 0.798 |